Burrows Scott L sold SYRE
August 3, 2026 · Form 4 insider transaction
Burrows Scott L sold 100 shares of Spyre Therapeutics, Inc. at $97.10 per share, a transaction worth $9.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$97.10
Total value
$9.7K
InsiderBurrows Scott L
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after97,994
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.; Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.